Home   Chapter Home   Jobs   Conferences   Fellowships   Books

 

 

 

 

Breast-malignant, males, children

Ductal carcinoma, NOS [no specific type]

 

Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.

Reviewer: Daniel Visscher, M.D., University of Michigan Hospitals, February 2009 (see Reviewers page)

Revised: 22 September 2009

Last major update: September 2009

Copyright: (c) 2002-2009, PathologyOutlines.com, Inc.

 

Definition

=========================================================================

● Most common type of invasive breast carcinoma (75-80%)

● Lacks features of any other subtypes (i.e. is a diagnosis of exclusion)

● Arises from terminal duct lobular unit (as does lobular carcinoma), not ductal epithelium, so nomenclature is not actually accurate

 

Terminology

=========================================================================

● Also called invasive ductal carcinoma, no special / specific type (NST)

 

Clinical

=========================================================================

● In patients >65 years, 87% of patients have “no special type” (Crit Rev Oncol Hematol 2008;67:263)

● Presence of focal neuroendocrine features has no prognostic significance (Hum Path 2003;34:1001)

                                                               

Case reports

=========================================================================

● With neuroendocrine carcinoma in morphologically composite tumor (Archives 2003;127:e131)

 

Gross description

=========================================================================

● Firm, poorly circumscribed, contracts from surrounding tissue, hard cartilaginous consistency, grating sound when scraped, streaks of chalky white elastotic stroma penetrating surrounding stroma (“crab like”), calcification

● Large tumors have hemorrhage, necrosis and cystic degeneration

● May be fixed to chest wall and cause skin dimpling or nipple retraction

 

Gross images

=========================================================================

 

                    

Irregular borders, infiltrating into adjacent tissue

 

 

                                      

Central necrosis and hemorrhage                AFIP image           Large irregular mass

 

 

               

Possible central necrosis                                                           Chalky streaks

 

Micro description

=========================================================================

● Sheets, nests, cords or individual cells

● Tubular formations are prominent in well differentiated tumors but absent in poorly differentiated tumors

● Tumor cells are more pleomorphic than lobular carcinoma

● Stroma usually desmoplastic and may obscure tumor cells

● Calcification in 60% of cases, variable necrosis

● Elastosis involves wall of vessels and ducts and causes grossly noted chalky streaks

● Often DCIS (up to 80%), perineural invasion (28%)

● Mitotic figures are often prominent

● Mast cells are associated with low grade tumors

● Uncommon features: eosinophils (BMC Cancer 2007;7:165), intraluminal crystalloids (Archives 1997;121:593)

● No myoepithelial cell lining (as seen in DCIS or benign lesions)

 

Angiolymphatic invasion:

● In 35% - differs from tissue retraction because:

● (a) occurs outside margin of carcinoma

● (b) does not conform precisely to space it is in

● (c) endothelial lining is present and is CD31+, Factor VIII+

● (d) blood vessels are in vicinity

● (e) see also Prognostic Factors-Angiolymphatic invasion

 

Micro images

=========================================================================

See other subtypes and topics for more images

 

Common histologic features

                                    

Infiltration of fibroadipose                DCIS and microcalcifications          With cribriform DCIS

 

 

                                       

Occult invasive carcinoma              Primary tumor with lymphocytic infiltration and fibrous stromal

and DCIS (arrows) - AFIP                  reaction that contains invasive carcinoma around a duct with DCIS

 

 

Chalky streaks correspond

to elastic fibers (van Gieson stain)

 

 

            

Resembling comedo DCIS but negative for myoepithelial markers (cocktail)

 

 

                        

Desmoplastic stroma               Focal lobular features             Multinucleated giant cells (arrows)

 

 

i1543-2165-128-9-996-f01                                                                   

Minimal tumor in core biopsy (fig 3a and 3b)              Perineural invasion (AFIP)

 

 

Angiolymphatic invasion

          

 

          

 

                                                                      

Arrow points to possible blood vessel                         #2-elastic stain accentuates the venous

invaded by carcinoma #1 (AFIP)                                     elastica involved by carcinoma and an artery below

 

 

Not angiolymphatic invasion, but shrinkage artifact with partly necrotic tumor in space created by shrinkage, no endothelial cells are present, elastic stain highlights elastic tissue in walls of vessels;  marked lymphoplasmacytic infiltrate

 

 

Not angiolymphatic invasion

 

 

Grading:

                    

Low grade

 

 

    

Intermediate Grade

 

 

                                   

High grade

 

 

Stains:

    

ER+                              E-cadherin+

 

 

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

CD10 and smooth muscle actin

 

 

                                                     

Stromal mast cells (c-kit/CD117+)                 Topoisomerase

 

 

Mast cells (stained with tryptase) are associated with low grade ER+ tumors

 

Other images: PR+calponin negative (normal ducts are positive)

 

Cytology description

=========================================================================

● Can use cellular pleomorphism, nuclear size, nuclear margin, nucleoli, naked tumor nuclei and mitoses to assess cytologic tumor grade, which correlates with histologic grade (Diagn Cytopathol 2003;29:185)

 

Cytology Images

=========================================================================

 

                    

Ductal carcinoma                                                                                                                   Figure A

 

 

    

Poorly differentiated ductal carcinoma

 

Virtual Slides

=========================================================================

 

 

Core biopsy

 

Invasive ductal carcinoma

 

Other:  With cancerization of lobules

 

Positive stains

=========================================================================

● CK8/18, CK19, CK7, EMA, E-cadherin (AJCP 2006;125:377), ER (70%)

● Also milk fat globule, lactalbumin, CEA, B72.3, BCA-225

● Glycogen (60%), mucin (moderate/marked in 20%), cytokeratin 5/6 (30%)

● S100 (10-45%), HER2 (15-30%), RCC Ma (renal cell carcinoma marker)

● CD5 clone 4C7 (Archives 2001;125:781)

Note: laminin, collagen IV and myoepithelial markers often show no or discontinuous staining

 

Negative stains

=========================================================================

CK20

Myoepithelial markers - p63 (positive in benign lesions, AJSP 2001;25:1054), CD10 (Mod Path 2002;15:397), calponin

 

Electron Microscopy

=========================================================================

● Glandular differentiation (microvilli and terminal bars on luminal side)

 

Differential Diagnosis

=========================================================================

● Cases with necrosis may resemble DCIS (J Med Case Reports 2007 Sep 8;1:83)

 

Videos

=========================================================================

Ductal carcinoma

 

Additional References

=========================================================================

Stanford University

 

End of Breast – Malignant, Males, Children > Ductal carcinoma, NOS [no specific type]

 

 

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment.  This website should not be used as a substitute for the advice of a licensed physician.

 

All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc.  Information from third parties may also be protected by copyright.  Please contact us at copyrightPathOut@gmail.com with any questions.